Randomized trial finds drug therapy reduces hot flashes during prostate cancer treatment

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
ascopubs.org

Randomized, placebo-controlled trial of atorvastatin to prevent hearing loss in patients with head and neck squamous cell carcinoma receiving cisplatin based chemoradiation (CRT).

A randomized phase III clinical trial of yoga for chemotherapy-induced peripheral neuropathy treatment (YCT). Acupuncture for preventing progression of taxane-induced peripheral neuropathy (ATP): A ...
Ophthalmology Times

Belite Bio completes enrollment in phase 2/3 DRAGON II trial for STGD1

Belite Bio completes enrollment in phase 2/3 DRAGON II clinical trial evaluating tinlarebant for the treatment of Stargardt ...
ascopubs.org

A randomized, double-blind, placebo-controlled trial of metformin in reducing progression among men on expectant management for low-risk prostate cancer: The MAST (Metformin ...

Cabazitaxel with abiraterone versus abiraterone alone randomized trial for extensive disease following docetaxel: The CHAARTED2 trial of the ECOG-ACRIN Cancer Research Group (EA8153). This is an ASCO ...
The New England Journal of Medicine

A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...
The New England Journal of Medicine

A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina

Percutaneous coronary intervention (PCI) is frequently performed to reduce the symptoms of stable angina. Whether PCI relieves angina more than a placebo procedure in patients who are not receiving ...